We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+4.72%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$353M
AUM Growth
+$18.3M
Cap. Flow
+$4.78M
Cap. Flow %
1.35%
Top 10 Hldgs %
27.53%
Holding
115
New
5
Increased
40
Reduced
34
Closed
2

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$564K
2
CHRW icon
C.H. Robinson
CHRW
+$524K
3
GPI icon
Group 1 Automotive
GPI
+$236K
4
AAPL icon
Apple
AAPL
+$92.4K
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$86.8K

Sector Composition

Rank Sector Weight
1 Technology 14.43%
2 Healthcare 13.36%
3 Consumer Staples 11.59%
4 Industrials 10.86%
5 Consumer Discretionary 9.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GE icon
101
GE Aerospace
GE
$374B
$265K 0.08%
3,023
+154
+5% +$12.5K
DIA icon
102
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.8B
$244K 0.07%
710
+40
+6% +$13.5K
YUMC icon
103
Yum China
YUMC
$16.5B
$244K 0.07%
4,320
WOR icon
104
Worthington Enterprises
WOR
$2.75B
$243K 0.07%
5,677
MAS icon
105
Masco
MAS
$14.1B
$229K 0.06%
+4,000
New +$209K
NVDA icon
106
NVIDIA
NVDA
$4.86T
$228K 0.06%
+5,400
New +$179K
A icon
107
Agilent Technologies
A
$39.1B
$225K 0.06%
1,879
IWF icon
108
iShares Russell 1000 Growth ETF
IWF
$121B
$223K 0.06%
+3,244
New +$206K
IXN icon
109
iShares Global Tech ETF
IXN
$8.32B
$223K 0.06%
+3,600
New +$204K
LOW icon
110
Lowe's Companies
LOW
$117B
$221K 0.06%
+980
New +$204K
CLX icon
111
Clorox
CLX
$11.6B
$218K 0.06%
1,375
ADM icon
112
Archer Daniels Midland
ADM
$38.2B
$217K 0.06%
2,880
TUP
113
DELISTED
Tupperware Brands Corporation
TUP
$31K 0.01%
39,344
CHRW icon
114
C.H. Robinson
CHRW
$17.4B
-5,280
Closed -$524K
GPI icon
115
Group 1 Automotive
GPI
$3.42B
-1,046
Closed -$236K

Similar funds

Boston Research & Management's Q2 2023 Portfolio in Review

As of Q2 2023, Boston Research & Management held 115 positions worth $353M, up 5.5% from $335M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Boston Research & Management's Q2 2023 filing shows 5 new, 40 increased, 34 reduced and 2 closed positions. Its largest new stake was Masco: 4,000 shares worth $229K. The largest sale was Microsoft, an estimated $564K.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Boston Research & Management's largest Q2 2023 buy was Masco: 4,000 shares worth $229K.
  • Boston Research & Management added most to Sysco in Q2 2023, an estimated $3.54M increase.
  • Boston Research & Management's biggest Q2 2023 reduction was Microsoft, cutting an estimated $564K.
  • Boston Research & Management fully exited C.H. Robinson in Q2 2023, selling an estimated $524K.
  • Boston Research & Management's ten largest holdings make up 28% of its $353M portfolio in Q2 2023.
  • Boston Research & Management opened 5 new positions and closed 2 in Q2 2023.
  • Boston Research & Management's portfolio value rose 5.5% quarter-over-quarter to $353M.

Based on Boston Research & Management's 13F filing for Q2 2023, filed 1 Aug 2023.